Rosenberg JE, Park SH, Kozlov V, Dao TV, et al. Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU). J Clin Oncol 2023;41:43-53.
PMID: 35737919